Allurion Technologies Inc.
ALUR•NYSE•Healthcare•Medical Devices

About Allurion Technologies

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company operates in Spain, France, Turkey, and internationally. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

Company Information

SectorHealthcare
IndustryMedical Devices
CEOShantanu Gaur
Founded2009
Employees137
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNYSE (NYSE)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Websitewww.allurion.com
Phone508 647 4000
Address
11 Huron Drive Natick, Massachusetts 01760 United States

Corporate Identifiers

CIK0001964979
CUSIP02008G102
ISINUS02008G2012
SIC3841

Leadership Team & Key Executives

Dr. Shantanu K. Gaur M.D.
Co-Founder, Chief Executive Officer, President, Principal Financial and Accounting Officer and Director
Ojas A. Buch
Chief Operating Officer
Brendan Michael Gibbons J.D.
Chief Legal Officer and Corporate Secretary
Dr. Samuel G. Levy
Co-Founder
Dr. Ram Chuttani M.D.
MD, Chief Medical Officer and Founding Partner
Alexandra van der Stap
Vice President of Global Marketing
Laurent Laffineur
Vice President of International Sales and Marketing
Matt Wright
Vice President of People